Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication regarding notice intimating the investors about the opening of a Special Window for...
15 Apr, 2026 | 03:32pm • Source: NSE
We would like to inform you that the Company has received four Awards from the Presiding Officer (in the rank of Additional District Judge) of...
10 Apr, 2026 | 04:21pm • Source: BSE
We are enclosing herewith a certificate dated 01.04.2026, issued by Skyline Financial Services Pvt. Ltd., Registrar and Transfer Agent of the Company, confirming compliance under...
07 Apr, 2026 | 12:01pm • Source: BSE
We would like to inform you that no share has been dematerialised during the month of March 2026. A copy of the certificate obtained from...
07 Apr, 2026 | 11:57am • Source: BSE
In continuation to our letter dated 06.03.2026, we are pleased to inform you that Deputy Commissioner of Income Tax has issued a rectified Assessment Order...
07 Apr, 2026 | 11:54am • Source: BSE
In continuation to our letter dated 02.03.2026, we are pleased to inform you that the Deputy Commissioner of Income Tax has issued a rectified Assessment...
07 Apr, 2026 | 11:48am • Source: BSE
We would like to inform you that Mr. Mukul Gupta (DIN: 00254597), Independent Director of the Company has completed his second and final term of...
01 Apr, 2026 | 09:43am • Source: BSE
We would like to inform you that Mr. Mukul Gupta (DIN: 00254597), Independent Director of the Company has completed his second and final term of...
01 Apr, 2026 | 09:26am • Source: BSE
We would like to inform you that CA Rajesh Jain, Independent Director of the Company and its material wholly owned subsidiary, Panacea Biotec Pharma Limited...
30 Mar, 2026 | 04:53pm • Source: BSE
We would like to inform you that with respect to the appeals filed by the Company in the Office of the Commissioner of Income Tax...
27 Mar, 2026 | 05:50pm • Source: BSE
We would like to inform you that the trading window of the Company shall remain closed for all the Designated Persons (including their immediate relatives)...
24 Mar, 2026 | 04:27pm • Source: BSE
We are pleased to inform you that the Company''s wholly owned subsidiary, Panacea Biotec Pharma Ltd. (PBPL) has received an Order dated 10.03.2026 issued by...
11 Mar, 2026 | 02:49pm • Source: BSE
We would like to inform you that the Company has received on March 06, 2026, a Demand Order dated March 01, 2026, from the Office...
06 Mar, 2026 | 05:46pm • Source: BSE
Please find enclosed herewith demat status report for the month of February 2026.
06 Mar, 2026 | 02:17pm • Source: BSE
We would like to inform you that the Company has received on 01.03.2026, a Demand Order dated 27.02.2026, from the Office of Deputy Commissioner of...
02 Mar, 2026 | 12:41pm • Source: BSE
Please find enclosed herewith newspaper copies of the Extract of Statement of Unaudited Financial Results for quarter and nine months ended 31.12.2025.
12 Feb, 2026 | 03:50pm • Source: BSE
Please find enclosed details of shares dematerialised during January 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
06 Feb, 2026 | 03:32pm • Source: BSE
Please find attached outcome of inspection by National Centre for Public Health and Pharmacy, Hungary at manufacturing facility of the Company''s material wholly owned subsidiary,...
05 Feb, 2026 | 02:52pm • Source: BSE
Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and...
02 Feb, 2026 | 03:42pm • Source: BSE